Parkin; Jacqueline

Patent Applications and Registrations

Patent applications and USPTO patent grants for Parkin; Jacqueline.The latest application filed is for "use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylb- enzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease".

Company Profile

6.4.5

Parkin; Jacqueline - London GB
PARKIN; Jacqueline - US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylb- enzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease Grant 11,234,967 - Parkin , et al. February 1, 2	2022-02-01
Dosage regimen for the treatment of acute exacerbations of chronic obstructive pulmonary disease Grant 11,129,810 - Orford , et al. September 28, 2	2021-09-28
Use Of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylb- Enzamide In The Prevention Or Reduction Of Acute Exacerbations Of Chronic Obstructive Pulmonary Disease App 20200383950 - PARKIN; Jacqueline ; et al.	2020-12-10
Use Of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylb- Enzamide In The Treatment Of Acute Exacerbations Of Chronic Obstructive Pulmonary Disease App 20200352909 - MACKINNON; Alastair ; et al.	2020-11-12
Dosage Regimen For The Treatment Of Acute Exacerbations Of Chronic Obstructive Pulmonary Disease App 20200281896 - ORFORD; Colin ; et al.	2020-09-10
Dosage regimen for the treatment of acute exacerbations of inflammatory conditions Grant 10,617,674 - Orford , et al.	2020-04-14
Dosage regimen for the treatment of acute exacerbations of chronic obstructive pulmonary disease Grant 10,603,306 - Orford , et al.	2020-03-31
Dosage Regimen For The Treatment Of Acute Exacerbations Of Inflammatory Conditions App 20190091203 - ORFORD; Colin ; et al.	2019-03-28
Dosage Regimen For The Treatment Of Acute Exacerbations Of Chronic Obstructive Pulmonary Disease App 20190060279 - ORFORD; Colin ; et al.	2019-02-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.